Drug Profile
Research programme: personalised systemic lupus erythematosus therapeutics - Berg Pharma/Medical University of South Carolina
Alternative Names: Systemic lupus erythematosus therapeutics - Berg Pharma/Medical University of South CarolinaLatest Information Update: 24 Feb 2023
Price :
$50
*
At a glance
- Originator Berg Pharma; Medical University of South Carolina
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Systemic lupus erythematosus
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for research development in Systemic-lupus-erythematosus in USA
- 25 Oct 2018 Personalised systemic lupus erythematosus therapeutics are still in research phase for Systemic lupus erythematosus in USA
- 28 Jun 2018 No recent reports of development identified for research development in Systemic-lupus-erythematosus in USA